Contact us Cell and Gene Therapies HOMEINNOVATIONS & THERAPEUTIC EXPERTISETHERAPEUTIC AREASCELL AND GENE THERAPIES Leveraging the expertise and insights of former regulators For biopharmaceutical companies, the heterogeneity of cell and gene therapies presents unprecedented technical, logistical, and strategic challenges. To help our customers navigate this complexity, Parexel brings expertise from former regulators – experts who leverage their first-hand experience of how regulators think to help our customers proceed with confidence. Our team of 80+ former regulators includes 6 from the FDA Office of Tissues and Advanced Therapies (OTAT) in CBER – including the supervisory medical reviewer from one of the first approved CAR-T cell therapies. The team also includes CMC Regulatory experts from EMA and MHRA. Our global Cell and Gene therapies working group was formed in 2016 to provide a complete suite of solutions to support the needs of our customers, aggregating best practices from medical, regulatory, feasibility, clinical operations, logistics, value and access and commercial strategy. Parexel has experience with multiple cell and gene therapies, including therapies for neurology and metabolic indications as well as oncology. Our services include: Non-clinical and clinical development strategy. Full-service and FSP clinical operations with distinct, custom operating models for cell or gene therapy trials. An established network of over 365 fully accredited sites with full CGT capability. Patient recruitment and retention strategies delivered in partnership with our Patient Innovation Center and patient-focused protocol optimization teams to overcome challenges with low and hard-to-find patient populations. Genomics research, methods, and resources. In-house Clinical Trial Supply & Logistics services to support complex requirements, import/export, and in-country capabilities to distribute temperature-controlled products, including CAR-T trial requirements. Regulatory and CMC consulting. GTP, GMP and GCP (GXP) compliance. Market access strategy and value communications. Over the last 5 years, Parexel’s Cell and Gene therapy experience included: Genomics and Biomarkers: Answers in the Blood Watch now Cell and Gene Therapy Clinical Trials Five competencies for operational excellence in cell and gene therapy clinical trials. Learn more Fulfilling the Promise Strategies for cell and gene therapies. Learn more Payer Insights for Cell and Gene Therapies Watch now We are always available for a conversation. Select Country Afghanistan Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Colombia Comoros Congo Costa Rica Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Isle of Man Indonesia Iran Iraq Ireland Israel Italy Ivory Coast Jersey Jamaica Japan Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kosovo Kuwait Kyrgyzstan Lao Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Northern Mariana Islands Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka St. Helena St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States minor outlying islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (U.S.) Wallis and Futuna Islands Yemen Zambia Zimbabwe CORPORATE LINKS About Us News Events Careers Education Investigators My Preferences Global Locations SOLUTIONS Parexel Biotech Clinical Development Consulting Medical Affairs Real-World Evidence FSP STUDIES & VOLUNTEERS About Trials Participate in a Trial GLOBAL STUDY LOCATIONS Baltimore, US Los Angeles, US London, UK Berlin, DE 275 Grove St., Suite 101C, Newton, MA 02466 +1 617 454 9300 2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713 +1 919 544 3170 © 2000-2021. Parexel International Corporation. All Rights Reserved. Privacy Policy Terms of Service Modern Slavery Statement Act By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies